METTL3 and cervical carcinoma: Interestingly, the mechanism by which METTL3 enhances MYC expression in an m6A-dependent manner to regulate tumor growth also exists in cervical cancer [70], bladder cancer [71], acute myeloid leukaemia [72], and oral squamous carcinoma [73].